| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
SELLAS Life Sciences Group Inc (NASDAQ: SLS)
SLS Technical Analysis
5
| As on 9th Jun 2023 SLS STOCK Price closed @ 1.64 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.80 & Strong Sell for SHORT-TERM with Stoploss of 5.65 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SLSSTOCK Price
| Open | 1.68 | Change | Price | % |
| High | 1.72 | 1 Day | -0.05 | -2.96 |
| Low | 1.64 | 1 Week | -0.08 | -4.65 |
| Close | 1.64 | 1 Month | 0.19 | 13.10 |
| Volume | 133750 | 1 Year | -4.35 | -72.62 |
| 52 Week High 7.18 | 52 Week Low 1.18 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SLS Daily Charts |
SLS Intraday Charts |
Whats New @ Bazaartrend |
SLS Free Analysis |
|
|
SLS Important Levels Intraday
| RESISTANCE | 1.79 |
| RESISTANCE | 1.74 |
| RESISTANCE | 1.71 |
| RESISTANCE | 1.68 |
| SUPPORT | 1.60 |
| SUPPORT | 1.57 |
| SUPPORT | 1.54 |
| SUPPORT | 1.49 |
SLS Forecast May 2024
| 4th UP Forecast | 6.19 |
| 3rd UP Forecast | 4.73 |
| 2nd UP Forecast | 3.83 |
| 1st UP Forecast | 2.93 |
| 1st DOWN Forecast | 0.35 |
| 2nd DOWN Forecast | -0.55 |
| 3rd DOWN Forecast | -1.45 |
| 4th DOWN Forecast | -2.91 |
SLS Weekly Forecast
| 4th UP Forecast | 3.51 |
| 3rd UP Forecast | 2.91 |
| 2nd UP Forecast | 2.54 |
| 1st UP Forecast | 2.17 |
| 1st DOWN Forecast | 1.11 |
| 2nd DOWN Forecast | 0.74 |
| 3rd DOWN Forecast | 0.37 |
| 4th DOWN Forecast | -0.23 |
SLS Forecast2024
| 4th UP Forecast | 13.65 |
| 3rd UP Forecast | 9.8 |
| 2nd UP Forecast | 7.42 |
| 1st UP Forecast | 5.04 |
| 1st DOWN Forecast | -1.76 |
| 2nd DOWN Forecast | -4.14 |
| 3rd DOWN Forecast | -6.52 |
| 4th DOWN Forecast | -10.37 |
SELLAS Life Sciences Group Inc ( NASDAQ USA Symbol : SLS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SLS Business Profile
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a wilms tumor 1 targeting peptide-based cancer immunotherapeutic agent, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It also develops nelipepimut-S, a cancer immunotherapy that is in Phase 2b clinical trials for the treatment of early stage breast cancer. The company has strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors. SELLAS Life Sciences Group, Inc. was founded in 2012 and is headquartered in New York, New York. Address: Times Square Tower, New York, NY, United States, 10036
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service